Skip to main content
. 2018 Apr 4;13(4):e0195306. doi: 10.1371/journal.pone.0195306

Table 3. Associations of physical activity and sedentary behavior variables with eGFRcrcys.

Model 1
Beta (95%CI)
Model 2
Beta (95%CI)
Model 3
Beta (95%CI)
Model 4
Beta (95%CI)
Total physical activity (h/day) 2.30 (1.46; 3.14) N/A N/A 1.55 (0.69; 2.40)
Lower intensity physical activity (h/day) 2.10 (1.08; 3.12) N/A N/A 1.49 (0.47; 2.50)
Higher intensity physical activity (10 min/day) 0.70 (0.39; 1.02) N/A 0.53 (0.21; 0.85) 0.31 (-0.02; 0.64)
Sedentary time (h/day) -0.88 (-1.23; -0.53) -0.71 (-1.08; -0.35) N/A -0.47 (-0.84; -0.10)
Sedentary breaks (10/day) 0.93 (0.26; 1.61) 0.80 (0.12; 1.47) 0.59 (-0.10; 1.27) 0.51 (-0.17; 1.19)
Prolonged sedentary bouts (#/day) -0.96 (-1.32; -0.61) -0.82 (-1.19; -0.46) -0.66 (-1.23; -0.09) -0.57 (-1.14; -0.01)
Average sedentary bout duration (min) -0.41 (-0.57; -0.26) -0.35 (-0.51; -0.20) -0.27 (-0.45–0.08) -0.23 (-0.41; -0.04)

Note: Betas represent the difference in eGFRcrcys per one unit increase in the independent variable. Boldface indicates statistical significance (P <0.05). The associations in models 1 were adjusted for age, sex, glucose metabolism status, waking time, educational level, smoking behavior, alcohol consumption, energy intake, comorbid disease, mobility limitation; in models 2 the associations with the sedentary behavior variables were additionally adjusted for HPA; in models 3 the associations with HPA and the sedentary behavior pattern variables were additionally adjusted for sedentary time; in models 4 all associations were additionally adjusted for office systolic blood pressure, use of antihypertensive medication, waist circumference, total-to-HDL cholesterol ratio, triglycerides, use of lipid-modifying medication, prevalent cardiovascular disease. All analyses were based on complete cases (n = 2,258).

Abbreviations: CI, confidence interval; eGFRcrcys, estimated glomerular filtration rate based on serum creatinine and serum cystatin C; HPA, higher intensity physical activity; HDL cholesterol, high-density lipoprotein cholesterol, N/A, not applicable.